Carfilzomib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1649 publications
Contemporary approach to desensitization: Targeted therapies for HLA sensitized pediatric heart transplant candidates - Study design and rationale.
Journal: JHLT open
Published: January 15, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.
Journal: Journal of medicinal chemistry
Published: January 08, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2026
Tellurophene-Tagged Carfilzomib Enables Single-Cell Mass Cytometric Mapping of Proteasome Activity.
Journal: ACS chemical biology
Published: November 18, 2025
Screening of Anti-Tumor Drugs that Enhance Antigen Presentation of AML Cells with TCR-Like Antibody
Journal: Zhongguo shi yan xue ye xue za zhi
Published: November 14, 2025
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.
Journal: Annals of hematology
Published: November 12, 2025
Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma.
Journal: International journal of molecular sciences
Published: October 30, 2025
Cancer targeting carfilzomib nanomedicine: a comprehensive review of delivery vehicles and efficacy.
Cancer targeting carfilzomib nanomedicine: a comprehensive review of delivery vehicles and efficacy.
Journal: Nanomedicine (London, England)
Published: October 29, 2025
Anthracyclines attenuate Nrf1-dependent proteolytic pathways and potentiate proteasome inhibitor cytotoxicity.
Journal: Molecular biology of the cell
Published: October 22, 2025
Carfilzomib triggers cardiotoxicity by suppressing SENP1-mediated deSUMOylation of DDX17.
Journal: Acta biochimica et biophysica Sinica
Published: October 11, 2025
Machine Learning Framework for Multi-Endpoint Quantum Dot Toxicity Prediction with Organoid Validation and Drug Target Discovery.
Journal: Toxics
Published: October 09, 2025
Definition and Classification of Pulmonary Hypertension
Journal: Pneumologie (Stuttgart, Germany)
Published: October 06, 2025
Last Updated: 02/24/2026